DK0852497T3 - Anvendelse af prostanderivater og kombination deraf med antibiotika i behandling af bakterieinfektioner - Google Patents

Anvendelse af prostanderivater og kombination deraf med antibiotika i behandling af bakterieinfektioner

Info

Publication number
DK0852497T3
DK0852497T3 DK96929216T DK96929216T DK0852497T3 DK 0852497 T3 DK0852497 T3 DK 0852497T3 DK 96929216 T DK96929216 T DK 96929216T DK 96929216 T DK96929216 T DK 96929216T DK 0852497 T3 DK0852497 T3 DK 0852497T3
Authority
DK
Denmark
Prior art keywords
pct
combination
antibiotics
treatment
bacterial infections
Prior art date
Application number
DK96929216T
Other languages
English (en)
Inventor
Dr Scholz Peter
Dr Weber Joerg
Dr Angstwurm Klemens
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0852497T3 publication Critical patent/DK0852497T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK96929216T 1995-08-11 1996-08-06 Anvendelse af prostanderivater og kombination deraf med antibiotika i behandling af bakterieinfektioner DK0852497T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19530884A DE19530884C2 (de) 1995-08-11 1995-08-11 Verwendung von Prostan-Derivaten sowie deren Kombination mit Antibiotika zur Behandlung von bakteriellen Meningitis
PCT/EP1996/003481 WO1997006806A1 (en) 1995-08-11 1996-08-06 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections

Publications (1)

Publication Number Publication Date
DK0852497T3 true DK0852497T3 (da) 2002-08-12

Family

ID=7770106

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96929216T DK0852497T3 (da) 1995-08-11 1996-08-06 Anvendelse af prostanderivater og kombination deraf med antibiotika i behandling af bakterieinfektioner

Country Status (24)

Country Link
US (1) US6040336A (da)
EP (1) EP0852497B1 (da)
JP (1) JPH11510809A (da)
CN (1) CN1080562C (da)
AT (1) ATE219368T1 (da)
AU (1) AU702706B2 (da)
BR (1) BR9609932A (da)
CA (1) CA2228036A1 (da)
CZ (1) CZ291534B6 (da)
DE (2) DE19530884C2 (da)
DK (1) DK0852497T3 (da)
ES (1) ES2181907T3 (da)
HU (1) HUP9802450A3 (da)
IL (1) IL122826A (da)
MX (1) MX9801118A (da)
NO (1) NO316424B1 (da)
PL (1) PL184840B1 (da)
PT (1) PT852497E (da)
RU (1) RU2201232C2 (da)
SK (1) SK284195B6 (da)
TR (1) TR199800128T1 (da)
UA (1) UA54397C2 (da)
WO (1) WO1997006806A1 (da)
ZA (1) ZA966775B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6663967B1 (en) * 2000-11-17 2003-12-16 Bryant Rubber Corporation Moldable silicone elastomers having selective primerless adhesion
HU227157B1 (en) * 2001-07-30 2010-09-28 Chinoin Gyogyszer Es Vegyeszet Production of beraprost ester by selective oxidation
EP2269611B1 (en) * 2006-11-16 2016-03-23 Gemmus Pharma Inc. EP2 and EP4 agonists as agents for the treatment of influenza A viral infection
EP2803365A1 (en) 2013-05-14 2014-11-19 Commissariat A L'energie Atomique Et Aux Energies Alternatives Use of clonazepam in combination with antibiotic in the treatment of bacterially induced meningitis
WO2021163400A1 (en) 2020-02-12 2021-08-19 Cytoagents, Inc. Compositions and methods for treating coronavirus infections

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US447802A (en) * 1891-03-10 Irvest williams
DE2845770A1 (de) * 1978-10-19 1980-04-30 Schering Ag Neue prostacyclin-derivate und verfahren zu ihrer herstellung
JPS58124778A (ja) * 1982-01-20 1983-07-25 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
US4665088A (en) * 1984-11-14 1987-05-12 The Research Foundation Of State University Of New York (E-Z)-4,5,9-trithiadodeca-1,6,11-triene 9-oxides
IL81601A0 (en) * 1986-02-18 1987-09-16 Syntex Inc Anti-infective injectable composition
RU2024258C1 (ru) * 1988-01-20 1994-12-15 Центр по химии лекарственных средств Антибактериальное средство
DE3933027A1 (de) * 1989-09-29 1991-04-11 Schering Ag Kombinationspraeparat mit antithrombotischer wirkung
RU2033791C1 (ru) * 1990-03-20 1995-04-30 Гематологический научный центр РАМН Средство, обладающее антиагрегационной активностью
DE4104607A1 (de) * 1991-02-12 1992-08-13 Schering Ag Prostacyclin- und carbacyclinderivate als mittel zur behandlung von fiebrigen erkrankungen
EP0758233B1 (en) * 1994-04-21 2003-12-03 Schering Aktiengesellschaft Pde iv inhibitors for treating multiple sclerosis

Also Published As

Publication number Publication date
JPH11510809A (ja) 1999-09-21
DE69621939D1 (de) 2002-07-25
SK284195B6 (sk) 2004-10-05
US6040336A (en) 2000-03-21
NO316424B1 (no) 2004-01-26
HUP9802450A2 (hu) 1999-02-01
CZ41498A3 (cs) 1998-09-16
HK1015707A1 (en) 1999-10-22
WO1997006806A1 (en) 1997-02-27
RU2201232C2 (ru) 2003-03-27
HUP9802450A3 (en) 1999-08-30
ATE219368T1 (de) 2002-07-15
NO980568L (no) 1998-02-10
PT852497E (pt) 2002-10-31
AU6871196A (en) 1997-03-12
DE69621939T2 (de) 2003-01-09
CZ291534B6 (cs) 2003-03-12
EP0852497A1 (en) 1998-07-15
AU702706B2 (en) 1999-03-04
DE19530884A1 (de) 1997-02-20
PL324884A1 (en) 1998-06-22
EP0852497B1 (en) 2002-06-19
TR199800128T1 (xx) 1998-04-21
CN1192684A (zh) 1998-09-09
SK15698A3 (en) 1998-06-03
UA54397C2 (uk) 2003-03-17
PL184840B1 (pl) 2002-12-31
BR9609932A (pt) 1999-06-08
CN1080562C (zh) 2002-03-13
IL122826A0 (en) 1998-08-16
IL122826A (en) 2001-11-25
DE19530884C2 (de) 1997-07-31
CA2228036A1 (en) 1997-02-27
ZA966775B (en) 1997-02-19
ES2181907T3 (es) 2003-03-01
MX9801118A (es) 1998-10-31
NO980568D0 (no) 1998-02-10

Similar Documents

Publication Publication Date Title
NO983074L (no) Karbamoyloksyderivater av mutilin og deres anvendelse som antibakterielle midler
BG103945A (bg) Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а
ES2131496T3 (es) Mejoras relativas a derivados glicopeptidicos.
ATE340171T1 (de) Piperazinderivate zur behandlung bakterieller infektionen
NO992492L (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
NO20005400L (no) Kinoloner anvendt som MRS-inhibitorer og baktericider
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
DE60042401D1 (de) Fab-i inhibitoren
PL358666A1 (en) 2-hydroxy-mutilin carbamate derivatives for antibacterial use
FI962488A0 (fi) HIV:n proteaasin inhibiittoreita
RU94030236A (ru) Производные 3 бета-алкенил-пенама, способ их получения, лекарственные средства и их применение для борьбы и предупреждения болезней
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
NO982778L (no) Morfinderivater med smertestillende virkning
ATE205505T1 (de) Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika
DK0852497T3 (da) Anvendelse af prostanderivater og kombination deraf med antibiotika i behandling af bakterieinfektioner
DK0801655T3 (da) Basiske prolinamidderivater af GE 2270 og GE 2270-lignende antibiotika
ATE337002T1 (de) Topische behandlung zur vorbeugung von augeninfektionen
FI874123A0 (fi) Heptanoyl-glu-asp-ala-aminosyra -immunostimulanter.
SE9603285D0 (sv) New compounds
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
BR0308734A (pt) Composto, composição farmacêutica, uso do composto, e, método para prevenir ou tratar infecção
ATE286728T1 (de) Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen
DK0774969T3 (da) HIV-proteaseinhibitor kombination
AP9701040A0 (en) Novel compounds.
IT1269873B (it) Nuovi derivati chinolonici, sintesi ed impiego come farmaci antibatterici